- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AFIB
Recent news which mentions AFIB
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022
January 20, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 14, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2022
January 14, 2022
From Benzinga
Rhythm Therapeutics rebrands as Inomagen Therapeutics
December 01, 2021
Tickers
AFIB
From PRUnderground
Overview Of Value Stocks In The Healthcare Sector
November 29, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 24, 2021
From Benzinga
70 Biggest Movers From Friday
November 15, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Surges 150 Points; Team Shares Drop
November 12, 2021
From Benzinga
Mid-Day Market Update: Everspin Jumps After Q3 Results; Acutus Medical Shares Plummet
November 12, 2021
From Benzinga
48 Stocks Moving In Friday's Mid-Day Session
November 12, 2021
From Benzinga
Mid-Morning Market Update: Markets Rise; AstraZeneca's COVID-19 Vaccine Turns Profitable In Third Quarter
November 12, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 12, 2021
November 12, 2021
From Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
From Benzinga
From InvestorPlace
Acutus Medical, Inc. (AFIB) Q3 2021 Earnings Call Transcript
November 12, 2021
Tickers
AFIB
From Motley Fool
Earnings Scheduled For November 11, 2021
November 11, 2021
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.